MainboardGMP
LIVE
LIVE GMP
Kwick Forensic Solutions Ltd₹+64·Lumino Industries Ltd₹+56·Sumax Engineering Ltd₹+25·Annu Projects Ltd₹+6·Skyways Air Services Ltd₹+42·ABH Healthcare Ltd₹0·Madhur Knit Crafts Ltd₹0·Hy-Tech Engineers Ltd₹+42·Symbiotec Pharmalab Ltd.₹+285·Rays of Belief Ltd₹+18·Deepa Jewellers Ltd₹+25·Ashutosh Fibre Ltd₹+25·Shanti Inorganics Ltd₹+31·Purple Style Labs Ltd₹0·Priority Jewels Ltd₹+40·Complete Sports & Management India Ltd₹0·Paluck Technologies Ltd₹+25·ESDS Software Solution Ltd₹+342·Augmont Enterprises Ltd₹+313·Tempsens Instruments (India) Ltd₹+305·Dhanwel Hybrid Seeds Ltd₹0·Gaja Alternative Asset Management Ltd₹+18·Mopshop Distribution Ltd₹0·Sunshine Pictures Ltd₹+80·Shankesh Jewellers Ltd₹+2·Lalithaa Jewellery Mart Ltd₹+40·Horizon Industrial Parks Ltd₹+2·Technocrats Plasma Systems Ltd₹+18·Kwick Forensic Solutions Ltd₹+64·Lumino Industries Ltd₹+56·Sumax Engineering Ltd₹+25·Annu Projects Ltd₹+6·Skyways Air Services Ltd₹+42·ABH Healthcare Ltd₹0·Madhur Knit Crafts Ltd₹0·Hy-Tech Engineers Ltd₹+42·Symbiotec Pharmalab Ltd.₹+285·Rays of Belief Ltd₹+18·Deepa Jewellers Ltd₹+25·Ashutosh Fibre Ltd₹+25·Shanti Inorganics Ltd₹+31·Purple Style Labs Ltd₹0·Priority Jewels Ltd₹+40·Complete Sports & Management India Ltd₹0·Paluck Technologies Ltd₹+25·ESDS Software Solution Ltd₹+342·Augmont Enterprises Ltd₹+313·Tempsens Instruments (India) Ltd₹+305·Dhanwel Hybrid Seeds Ltd₹0·Gaja Alternative Asset Management Ltd₹+18·Mopshop Distribution Ltd₹0·Sunshine Pictures Ltd₹+80·Shankesh Jewellers Ltd₹+2·Lalithaa Jewellery Mart Ltd₹+40·Horizon Industrial Parks Ltd₹+2·Technocrats Plasma Systems Ltd₹+18·
Home IPOs Rays of Belief Ltd
RA
Rays of Belief Ltd
UPCOMING NSE & BSE Bookbuilding IPO Fresh capital only
GREY MARKET PREMIUM
₹ + 18
+8% expected return
EST. LISTING PRICE
₹257
Issue Price: ₹ 239
Issue Price
₹239
Face Value
₹10
Lot Size
62 shares
Open Date
01 Sep 2026
Close Date
03 Sep 2026
Allotment
04 Sep 2026
Listing Date
08 Sep 2026
Exchange
NSE & BSE
About the Company

Incorporated in 2017, Rays of Belief Ltd. is a for-profit social enterprise providing personalised intervention plans for children with Neurodevelopmental Disorders (NDDs), including Autism Spectrum Disorder (ASD), ADHD, Down Syndrome, Cerebral Palsy, Intellectual Disability, Learning Disabilities and Global Developmental Delays.

The Company started its first centre in Gurgaon in 2018 and has since expanded from 71 centres in Fiscal 2023 to 136 centres as of March 31, 2026, under its brand name Mom’s Belief. These centres are spread across 57 cities and 20 states and union territories in India, with a strong presence in Tier 2 cities. The network includes 42 Tier 1, 77 Tier 2 and 17 Tier 3 centres, helping extend developmental care to underserved and semi-urban areas.

The Company primarily serves children aged 18 months to 12 years, while specialised programs are available for children up to 15 years, focusing on vocational and life skills. Its multidisciplinary services include early intervention, parental guidance, occupational therapy, language therapy and family support programs.

The centres are equipped with 150+ teaching tools, while home-based learning kits provide access to 2,000+ teaching tools, supported by regular follow-ups and progress monitoring. As of March 31, 2026, the Company had a team of 340+ full-time clinical professionals.

In June 2025, Rays of Belief Ltd. acquired Mom's Belief US, Inc. as its wholly owned subsidiary and Allergy and Immunology Virginia, LLC as its step-down subsidiary in the USA. The acquisition added three centres in Virginia, located in Salem, Lynchburg and Roanoke.

Objects of the Issue
Purpose Amount (₹ Cr)
Company Learning Centres and Company Learning Centres in partnership with Licensed Professionals ₹27
School Collaboration Centres ₹6
Centre for Excellence and Research ₹2
Upskilling Academy ₹2
Technology (hardware) costs ₹4
Expenditure for lease payments for existing centres in India ₹14
Investment in Subsidiary, Moms Belief US Inc., for making lease / license payments for existing centres in the USA ₹10
Expenditure for brand awareness and inclusive outreach programs ₹10
Funding inorganic growth through unidentified acquisition and General corporate purposes
Lead Managers
Mefcom Capital Markets Ltd
Financial Summary Amount in ₹ Crore
Metric 31 Mar 2026 31 Mar 2025 31 Mar 2024
Total Assets 51 26 13
Revenue 82 37 31
PAT 5 6 1
EBITDA 12 3 1
Net Worth 31 15 6
Reserves 15 15 5
Total Borrowing 4 4
Key Financial Ratios
ROE
22
ROCE
30
RONW
22
PAT Margin
6
EBITDA Margin
15
Debt/Equity
0
P/BV
16
Issue Details
Pre-Issue Shareholding
15,671,682 shares
Post-Issue Shareholding
20,901,682 shares
IPO Analytics Dashboard
LIVE
IPO Insights
📊
Valuation
Moderate
IPO Strength Score
4 / 10 Moderate
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB Not less than 75% of the Issue size
💼 NII / HNI Not more than 15% of the Issue
👤 Retail (RII) Not more than 10% of the Issue

* Amount calculated at upper price band (₹239) ·  ** Total includes all investor categories

Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 62
Min. Investment ₹14,818
Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ 3
Post-Issue EPS ?
₹ 2
IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 07 Sep 2026
  2. 2 📂 Credit of Shares to Demat 07 Sep 2026
Investor Interpretation
  • Pre-issue EPS of ₹3 compares to post-issue EPS of ₹2 after dilution.

This IPO has relatively lower interest or stretched valuation. Proceed with thorough research and caution.

Company Info
📍 J-1919, Basement, Chittranjan Park, New Delhi, Delhi, New Delhi, 110019
Visit Website
Registrar
Kfin Technologies Ltd
Check Allotment Status
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.